Skip to main content
Clinical Trials/NCT04714268
NCT04714268
Unknown
Not Applicable

Comparison of Aorto-iliac Endovascular Interventions With and Without the EndoNaut Workstation

Therenva1 site in 1 country150 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Aneurysm
Sponsor
Therenva
Enrollment
150
Locations
1
Primary Endpoint
Irradiation parameters: measurement of air Kerma (mGy)
Last Updated
5 years ago

Overview

Brief Summary

The aim of this retrospective, multicenter study is to demonstrate that the use of EndoNaut for aortoiliac endovascular procedures has a clinical impact for the patient (reduction in irradiation and the volume of contrast product) as well as for the nursing staff (reduction irradiation) compared to procedures performed without EndoNaut.

Detailed Description

Minimally invasive endovascular interventions are increasingly replacing conventional surgeries, and have become the therapeutic benchmark for a large number of pathologies thanks in particular to advances in image-guided therapy. Therenva offers a comprehensive and consistent lightweight navigation solution (EndoNaut®) for endovascular procedures. This navigation station makes it possible to secure and guide the interventional gesture by providing relevant information extracted during the preoperative phase. This information is rendered in augmented reality using artificial intelligence algorithms and digital simulation. This alternative solution to a hybrid room, but which offers equivalent functionality, is compatible with all operating rooms, regardless of the interventional environment. Benefits of imaging fusion remain to be assessed on a larger scale. The aim of this multicenter study is to demonstrate that the use of EndoNaut for aortoiliac endovascular procedures has a clinical impact for the patient (reduction in irradiation and the volume of contrast product) as well as for the nursing staff (reduction irradiation) compared to procedures performed without EndoNaut.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
January 1, 2022
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Therenva
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Unilateral or bilateral aorto-iliac or iliac aneurysm/stenosis
  • Suitable for endovascular repair
  • Major patients
  • Patients not opposed to their participation in the study

Exclusion Criteria

  • Patients requiring conventional surgical revascularization.

Outcomes

Primary Outcomes

Irradiation parameters: measurement of air Kerma (mGy)

Time Frame: At enrollment

Parameter given by the X-ray imaging device

Irradiation parameters: dose-area quantification (mGy/m2)

Time Frame: At enrollment

Parameter given by the X-ray imaging device

Irradiation parameters: evaluation of the Fluoroscopy duration (min)

Time Frame: At enrollment

Parameter given by the X-ray imaging device

Volume of contrast product used during the routine care procedure (ml)

Time Frame: At enrollment

Volume are reported in mL

Secondary Outcomes

  • Procedure time (min)(At enrollment)

Study Sites (1)

Loading locations...

Similar Trials